Back
28
Day Range
$50.70
$52.95
52-Week Range
$46.01
$72.16
Volume
1,777,887
50D / 200D Avg
$60.87
/
$57.62
Prev Close
$52.00
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (627 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 111.8 | 0.4 |
| P/B | 4.3 | 2.9 |
| ROE % | 3.7 | 3.9 |
| Net Margin % | 6.0 | 3.8 |
| Rev Growth 5Y % | 7.0 | 10.0 |
| D/E | 0.2 | 0.2 |
Analyst Price Target
Hold
$69.33
+32.2%
Low: $62.00
High: $79.00
Forward P/E
26.2
Forward EPS
$1.98
EPS Growth (est.)
+0.0%
Est. Revenue
1.2 B
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2030 |
$3.15
$3.10 – $3.21
|
1.7 B | 1 |
| FY2029 |
$3.03
$2.98 – $3.08
|
1.5 B | 1 |
| FY2028 |
$2.52
$2.22 – $2.76
|
1.4 B | 3 |
Key Takeaways
Revenue grew 6.98% annually over 5 years — modest growth
Earnings declined -56.34% over the past year
ROE of 3.68% is below average
Debt/Equity of 0.23 — conservative balance sheet
Generating 256.55M in free cash flow
P/E of 111.76 — premium valuation
Growth
Revenue Growth (5Y)
6.98%
Revenue (1Y)5.23%
Earnings (1Y)-56.34%
FCF Growth (3Y)8.95%
Quality
Return on Equity
3.68%
ROIC3.25%
Net Margin6.02%
Op. Margin8.38%
Safety
Debt / Equity
0.23
Current Ratio3.46
Interest Coverage12.02
Valuation
P/E Ratio
111.76
P/B Ratio4.27
EV/EBITDA82.98
Dividend Yield0.01%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 5.23% | Revenue Growth (3Y) | 3.58% |
| Earnings Growth (1Y) | -56.34% | Earnings Growth (3Y) | -49.27% |
| Revenue Growth (5Y) | 6.98% | Earnings Growth (5Y) | -14.97% |
| Profitability | |||
| Revenue (TTM) | 1.22B | Net Income (TTM) | 73.40M |
| ROE | 3.68% | ROA | 2.87% |
| Gross Margin | 64.80% | Operating Margin | 8.38% |
| Net Margin | 6.02% | Free Cash Flow (TTM) | 256.55M |
| ROIC | 3.25% | FCF Growth (3Y) | 8.95% |
| Safety | |||
| Debt / Equity | 0.23 | Current Ratio | 3.46 |
| Interest Coverage | 12.02 | Dividend Yield | 0.01% |
| Valuation | |||
| P/E Ratio | 111.76 | P/B Ratio | 4.27 |
| P/S Ratio | 6.73 | PEG Ratio | -1.97 |
| EV/EBITDA | 82.98 | Dividend Yield | 0.01% |
| Market Cap | 8.20B | Enterprise Value | 8.48B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1.22B | 1.16B | 1.14B | 1.11B | 931.03M |
| Net Income | 73.40M | 168.11M | 285.26M | 272.05M | 140.41M |
| EPS (Diluted) | 0.46 | 1.05 | 1.76 | 1.66 | 0.87 |
| Gross Profit | 790.27M | 769.73M | 769.82M | 756.50M | 632.85M |
| Operating Income | 102.26M | 206.69M | 298.94M | 296.59M | 237.30M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 2.56B | 2.70B | 2.64B | 2.29B | 2.26B |
| Total Liabilities | 639.06M | 635.02M | 672.18M | 593.79M | 691.72M |
| Shareholders' Equity | 1.92B | 2.07B | 1.97B | 1.70B | 1.56B |
| Total Debt | 444.06M | 419.54M | 454.97M | 325.97M | 420.55M |
| Cash & Equivalents | 162.19M | 151.79M | 180.57M | 172.57M | 199.09M |
| Current Assets | 608.30M | 617.42M | 621.48M | 605.56M | 510.61M |
| Current Liabilities | 175.85M | 159.38M | 128.51M | 176.02M | 152.28M |
Strategy Scores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#884 of 1052
Recent Activity
Entered
Cash Flow Compounder
Mar 24, 2026